The global DNA sequencing market size was estimated to be USD 12.40 billion in 2023 and is expected to reach at USD 107.26 billion by 2034 with a CAGR of 21.67% during the forecast period 2024-2034. Rising advancements in technology & bioinformatics, increasing use of Next-Generation and Whole-Genome Sequencing technologies in clinical diagnostics, ongoing progress in sequencing technologies has transformed genomics, heightened interest in genomics research & personalized medicine, growing adoption of technological innovations such as artificial intelligence & machine learning in genomics, surge in introduction of advanced DNA sequencing platform are some of the key factors boosting the market growth.
Surge in introduction of advanced DNA sequencing platform is predicted to boost the market growth during the forecast period. DNA sequencing is cost-effective, exhibiting high accuracy & speed, and can produce output from even small sample sizes. The evolution of DNA sequencing technologies, progressing from the first to the third generation, has contributed to the enhanced features of DNA sequencing systems. These advancements have attracted considerable interest, prompting market participants to introduce cutting-edge platforms in the DNA sequencing market. For instance, in March 2023, Illumina Inc. unveiled Connected Insights, a novel cloud-based software designed to facilitate tertiary analysis for clinical next-generation sequencing (NGS) data.
By product & services, consumables was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the increasing availability of reagents & kits tailored for different stages of library construction, such as DNA fragmentation, adapter ligation, & quality control, and surge in introduction of innovative tools. Additionally, services is predicted to grow at the fastest CAGR during the forecast period owing to a range of sequencing services is accessible in the market, encompassing thorough data analysis, library preparation, and the identification & quantification of DNA protein binding sites, and growing launch of novel tools by market players. For instance, in November 2023, Illumina Inc. has introduced the Global Health Access Initiative, aiming to facilitate access to pathogen sequencing tools for public health purposes in low- and middle-income countries (LMICs).
By technology, next-generation sequencing was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the advancements in technologies, along with decreasing sequencing time and costs, have made genome sequencing more economical and precise, and increase in partnerships and collaborations among market leaders. For instance, in January 2023, QIAGEN has declared a collaboration with Helix to co-develop Next-Generation Sequencing (NGS) companion diagnostics tailored for various hereditary diseases. Additionally, third-generation sequencing is predicted to grow at the fastest CAGR during the forecast period. This technology addresses the limitations of second-generation sequencing by incorporating simple sample preparation that eliminates the necessity for PCR amplification, thereby reducing the time and cost associated with sequencing. Furthermore, this technology has the capability to produce long reads surpassing several kilobases, which proves beneficial for resolving assembly challenges and addressing repetitive sites in complex genomes.
By workflow, sequencing was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the growing research & development activities, surge in technological advancements, and increasing focus on the development of new platforms. Additionally, data analysis is predicted to grow at the fastest CAGR during the forecast period owing to the rise in the adoption of whole genome sequencing and increasing introduction of software specifically designed for analysis and computation in this field. For instance, in October 2023, PacBio has introduced the PacBio WGS Variant Pipeline, offering a comprehensive and standardized computational approach for the analysis of HiFi whole genome sequencing (WGS) data.
By application, oncology was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the increase in the research & development activities on cancer for diagnostics & therapeutics, a rise in technological advancements, and an expanding use of Next-Generation Sequencing (NGS) in oncology. Additionally, consumer genomics is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness of personal health, a growing prevalence of paternity testing and genealogy, and a surge in the introduction of new products. For instance, in June 2023, Illumina Inc. has introduced PrimateAI-3D, an innovative artificial intelligence (AI) algorithm showcasing unparalleled accuracy in predicting genetic mutations accountable for diseases in patients.
By end-user, academic research was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the rising adoption of Sanger technology & Next-Generation Sequencing (NGS) in academic & institutional research projects, an increase in funding & investment initiatives, the proliferation of workshops, exhibitions, and symposiums, and a growing number of collaborations among market players. For instance, in August 2023, PacBio, in partnership with GeneDx, has disclosed a collaborative research initiative with the University of Washington. The objective is to investigate and comprehend the applications of long-read whole genome sequencing to enhance diagnostic effectiveness in neonatal care. Additionally, clinical research is predicted to grow at the fastest CAGR during the forecast period owing to the rising utilization of Next-Generation Sequencing (NGS) technologies in clinical testing, the incorporation of DNA analysis to explore tumor heterogeneity, an intensified effort in discovering novel cancer-related genes, and the detection of alterations linked to tumorigenesis.
North America region is anticipated for the highest revenue share during the forecast period owing to the increase in the adoption of DNA sequencing technology, the existence of numerous major players, and a growing implementation of strategic initiatives by prominent market participants. For instance, in August 2023, Complete Genomics, Inc., a company based in the United States, was honored with the "Oscars of Innovation" award by R&D World Magazine for its ultra-high throughput gene sequencer DNBSEQ-T20×2*("T20"). Novel advances in the regional market are anticipated to be driven by such recognitions and awards for innovative products. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the continuous advancements in HLA and prenatal NGS testing, a growing trend of collaborations among market players, and increasing progress in genomics. For instance, in July 2022, The All India Institute of Medical Sciences (AIIMS) Nagpur, in collaboration with JHPIEGO-USAID-RISE, has declared its plans to set up a facility for Whole Genome Sequencing (WGS).
Surge in introduction of advanced DNA sequencing platform is predicted to boost the market growth during the forecast period. DNA sequencing is cost-effective, exhibiting high accuracy & speed, and can produce output from even small sample sizes. The evolution of DNA sequencing technologies, progressing from the first to the third generation, has contributed to the enhanced features of DNA sequencing systems. These advancements have attracted considerable interest, prompting market participants to introduce cutting-edge platforms in the DNA sequencing market. For instance, in March 2023, Illumina Inc. unveiled Connected Insights, a novel cloud-based software designed to facilitate tertiary analysis for clinical next-generation sequencing (NGS) data.
By product & services, consumables was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the increasing availability of reagents & kits tailored for different stages of library construction, such as DNA fragmentation, adapter ligation, & quality control, and surge in introduction of innovative tools. Additionally, services is predicted to grow at the fastest CAGR during the forecast period owing to a range of sequencing services is accessible in the market, encompassing thorough data analysis, library preparation, and the identification & quantification of DNA protein binding sites, and growing launch of novel tools by market players. For instance, in November 2023, Illumina Inc. has introduced the Global Health Access Initiative, aiming to facilitate access to pathogen sequencing tools for public health purposes in low- and middle-income countries (LMICs).
By technology, next-generation sequencing was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the advancements in technologies, along with decreasing sequencing time and costs, have made genome sequencing more economical and precise, and increase in partnerships and collaborations among market leaders. For instance, in January 2023, QIAGEN has declared a collaboration with Helix to co-develop Next-Generation Sequencing (NGS) companion diagnostics tailored for various hereditary diseases. Additionally, third-generation sequencing is predicted to grow at the fastest CAGR during the forecast period. This technology addresses the limitations of second-generation sequencing by incorporating simple sample preparation that eliminates the necessity for PCR amplification, thereby reducing the time and cost associated with sequencing. Furthermore, this technology has the capability to produce long reads surpassing several kilobases, which proves beneficial for resolving assembly challenges and addressing repetitive sites in complex genomes.
By workflow, sequencing was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the growing research & development activities, surge in technological advancements, and increasing focus on the development of new platforms. Additionally, data analysis is predicted to grow at the fastest CAGR during the forecast period owing to the rise in the adoption of whole genome sequencing and increasing introduction of software specifically designed for analysis and computation in this field. For instance, in October 2023, PacBio has introduced the PacBio WGS Variant Pipeline, offering a comprehensive and standardized computational approach for the analysis of HiFi whole genome sequencing (WGS) data.
By application, oncology was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the increase in the research & development activities on cancer for diagnostics & therapeutics, a rise in technological advancements, and an expanding use of Next-Generation Sequencing (NGS) in oncology. Additionally, consumer genomics is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness of personal health, a growing prevalence of paternity testing and genealogy, and a surge in the introduction of new products. For instance, in June 2023, Illumina Inc. has introduced PrimateAI-3D, an innovative artificial intelligence (AI) algorithm showcasing unparalleled accuracy in predicting genetic mutations accountable for diseases in patients.
By end-user, academic research was the highest revenue-grossing segment in the global DNA sequencing market in 2023 owing to the rising adoption of Sanger technology & Next-Generation Sequencing (NGS) in academic & institutional research projects, an increase in funding & investment initiatives, the proliferation of workshops, exhibitions, and symposiums, and a growing number of collaborations among market players. For instance, in August 2023, PacBio, in partnership with GeneDx, has disclosed a collaborative research initiative with the University of Washington. The objective is to investigate and comprehend the applications of long-read whole genome sequencing to enhance diagnostic effectiveness in neonatal care. Additionally, clinical research is predicted to grow at the fastest CAGR during the forecast period owing to the rising utilization of Next-Generation Sequencing (NGS) technologies in clinical testing, the incorporation of DNA analysis to explore tumor heterogeneity, an intensified effort in discovering novel cancer-related genes, and the detection of alterations linked to tumorigenesis.
North America region is anticipated for the highest revenue share during the forecast period owing to the increase in the adoption of DNA sequencing technology, the existence of numerous major players, and a growing implementation of strategic initiatives by prominent market participants. For instance, in August 2023, Complete Genomics, Inc., a company based in the United States, was honored with the "Oscars of Innovation" award by R&D World Magazine for its ultra-high throughput gene sequencer DNBSEQ-T20×2*("T20"). Novel advances in the regional market are anticipated to be driven by such recognitions and awards for innovative products. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the continuous advancements in HLA and prenatal NGS testing, a growing trend of collaborations among market players, and increasing progress in genomics. For instance, in July 2022, The All India Institute of Medical Sciences (AIIMS) Nagpur, in collaboration with JHPIEGO-USAID-RISE, has declared its plans to set up a facility for Whole Genome Sequencing (WGS).
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
Study Coverage
- Market Forecast by Type, Material, Product, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: DNA Sequencing Market Report 2023 - 2034
DNA Sequencing Market Analysis & Forecast by Product & Services 2023 - 2034 (Revenue USD Bn)
- Services
- Instruments
- Consumables
DNA Sequencing Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Sanger Sequencing
- Third Generation DNA Sequencing
- Nanopore Sequencing
- Single-Molecule Real-Time Sequencing (SMRT)
- Next-Generation Sequencing
- Whole Exome Sequencing (WES)
- Whole Genome Sequencing (WGS)
- Targeted Sequencing & Resequencing)
DNA Sequencing Market Analysis & Forecast by Workflow 2023 - 2034 (Revenue USD Bn)
- Sequencing
- Data Analysis
- Pre-sequencing
DNA Sequencing Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Agrigenomics & Forensics
- Oncology
- Consumer Genomics
- Clinical Investigation
- Reproductive Health
- Metagenomics
- Epidemiology & Drug Development
- HLA Typing/Immune System Monitoring
- Others
DNA Sequencing Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Pharmaceutical & Biotechnology Companies
- Clinical Research
- Hospitals & Clinics
- Academic Research
- Others
DNA Sequencing Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. DNA Sequencing Market: Product & Services Estimates & Trend Analysis
8. DNA Sequencing Market: Technology Estimates & Trend Analysis
9. DNA Sequencing Market: Workflow Estimates & Trend Analysis
10. DNA Sequencing Market: Application Estimates & Trend Analysis
11. DNA Sequencing Market: End-user Estimates & Trend Analysis
12. Regional Market Analysis
13. North America DNA Sequencing Market
14. Europe DNA Sequencing Market
15. Asia Pacific DNA Sequencing Market
16. Latin America DNA Sequencing Market
17. MEA DNA Sequencing Market
18. Competitor Analysis
19. Company Profiles
Companies Mentioned
- PacBio
- Thermo Fisher Scientific Inc
- Myriad Genetics
- PerkinElmer Genomics
- Illumina Inc.
- F. Hoffmann-La Roche Ltd.
- BGI
- Bio-Rad Laboratories Inc.
- PierianDx
- Agilent Technology
- Macrogen Inc.
- Partek Incorporated
- QIAGEN
- Eurofins Scientific
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 12.4 Billion |
| Forecasted Market Value ( USD | $ 107.26 Billion |
| Compound Annual Growth Rate | 21.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
